Chai-2 Platform
AI platform for de novo protein design that works reliably.
Where it ranks
Current edition · updated Oct 20, 2026What it does
AI platform for de novo protein design that works reliably. Specify antibody format, achieve high success rates, faster experimentation cycles, and target specific antigen confirmations. Address challenging targets, design for epitope specificity, handle chemical modifications, and specify advanced design criteria.
- Drug discovery
- De novo protein design
- Antibody discovery
- AI-driven immunology research
- Category
- Drug discovery and biotech
- Built for
- Healthcare and life sciences
- Users
- Pharmaceutical companies, Life sciences companies, Commercial organizations, Academic researchers
- Public API
- Not offered
Not yet disclosed: deployment options, platforms, languages and support channels.
Pricing
Pricing isn't published
Chai Discovery doesn't list prices publicly. Ask them for a quote.
Security and compliance
As reported by Chai Discovery. Ask for audit reports before you buy.
- GDPRCompliant
- CCPA/CPRACompliant
Reviews
No reviews yet
Reviews come from people who use Chai-2 Platform at work. Share how your team uses it to help other buyers decide.
Alternatives
See the full rankingDiffuseSandbox
by Diffuse Bio
Sandbox for designing novel protein binders, enabling binder design in minutes on a laptop compared to spending weeks in a lab.
#2 in Design molecular candidates
ITO™ Platform
by 1910
Cloud-based end-to-end platform integrating massive multimodal data, frontier AI models, and high-throughput lab automation to deliver small and large molecule drug candidates f...
#3 in Design molecular candidates
PharmaSphere
by Receptor.AI
AI drug design platform with dedicated sub-platforms for Small Molecules, Peptides, and Proximity Inducers, combining 40+ experimentally validated AI methodologies for molecular...
#4 in Design molecular candidates
DeepChain Labs
by DeepChain
Experimental interface for multi-objective optimisation and interactive conditioning for flexible antibody design.
#5 in Design molecular candidates
DrugFlow Platform
by DrugFlow
AI-driven one-stop new drug discovery platform with proprietary core algorithms covering the entire drug discovery process, including target discovery, lead compound discovery,...
#6 in Design molecular candidates
SAR & De Novo
by META D3
AI powered Drug Discovery and Development platform for drug discovery steps from target identification to clinical trial success, associated with Partex.
#7 in Design molecular candidates
Is this your product?
Claim it to keep details accurate and submit evidence for the next ranking review.
Claim Chai-2 Platform